Boston Trust Walden’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,072
Closed -$282K 358
2022
Q2
$282K Hold
10,072
﹤0.01% 334
2022
Q1
$294K Hold
10,072
﹤0.01% 352
2021
Q4
$351K Hold
10,072
﹤0.01% 350
2021
Q3
$332K Hold
10,072
﹤0.01% 344
2021
Q2
$333K Buy
+10,072
New +$349K ﹤0.01% 348

Other funds holding GNTX

Boston Trust Walden's GNTX Position: Q3 2022 in Review

Boston Trust Walden sold out of Gentex (GNTX) in Q3 2022, closing a stake of 10,072 shares — an estimated $282K sold.

Boston Trust Walden first reported a position in GNTX in Q2 2021 and held it in 5 quarters. The position peaked at $351K in Q4 2021. 455 funds tracked by Wall St. Rank hold GNTX as of Q3 2022.

  • Boston Trust Walden reported no remaining Gentex position as of Q3 2022 after selling out during the quarter.
  • Boston Trust Walden sold 10,072 Gentex shares in Q3 2022, an estimated $282K.
  • Boston Trust Walden first reported a position in Gentex in Q2 2021 and held it in 5 quarters.
  • Boston Trust Walden's Gentex position peaked at $351K in Q4 2021.
  • 455 funds tracked by Wall St. Rank held Gentex as of Q3 2022.

Based on Boston Trust Walden's 13F filing for Q3 2022, filed 19 Oct 2022.